Metraipolis › archive › dc_bf2a96b15b82
Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases — Europe PMC PMID:41471389
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41471389
- DOI
- 10.3390/ph18121900
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:53:44.224Z
- SHA-256 of the archived text
73aeaab79fc6215c746682e7e399e8575b2eefb1a54a46a05f45ced8da915f43- Stable URL of this page
https://metraipolis.com/documento/dc_bf2a96b15b82
How to cite
Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases — Europe PMC PMID:41471389 — Europe PMC (en), https://europepmc.org/article/MED/41471389 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf2a96b15b82 (Metraipolis archive dc_bf2a96b15b82, sha256 73aeaab79fc6215c746682e7e399e8575b2eefb1a54a46a05f45ced8da915f43)
BibTeX
@misc{dcbf2a96b15b82,
title = {Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases — Europe PMC PMID:41471389},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41471389},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf2a96b15b82; sha256 73aeaab79fc6215c746682e7e399e8575b2eefb1a54a46a05f45ced8da915f43},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471389. Agents can read the archived copy with the MCP tool read_document.